Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Treasury Shares: 2022-2024

Historic Treasury Shares for Centessa Pharmaceuticals (CNTA) over the last 2 years, with Dec 2024 value amounting to $1.5 million.

  • Centessa Pharmaceuticals' Treasury Shares fell 22.54% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year decrease of 22.54%. This contributed to the annual value of $1.5 million for FY2024, which is 22.54% down from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Treasury Shares stood at $1.5 million for Q4 2024, which was down 38.29% from $2.4 million recorded in Q1 2024.
  • Centessa Pharmaceuticals' 5-year Treasury Shares high stood at $2.7 million for Q1 2023, and its period low was $715,432 during Q2 2022.
  • For the 3-year period, Centessa Pharmaceuticals' Treasury Shares averaged around $1.9 million, with its median value being $2.1 million (2023).
  • In the last 5 years, Centessa Pharmaceuticals' Treasury Shares spiked by 245.28% in 2023 and then fell by 22.54% in 2024.
  • Quarterly analysis of 3 years shows Centessa Pharmaceuticals' Treasury Shares stood at $1.8 million in 2022, then climbed by 8.02% to $1.9 million in 2023, then decreased by 22.54% to $1.5 million in 2024.
  • Its Treasury Shares was $1.5 million in Q4 2024, compared to $2.4 million in Q1 2024 and $1.9 million in Q4 2023.